Jefferies Upgrades Kodiak Sciences(KOD.US) to Buy Rating, Raises Target Price to $20
Cautious Approach: Kodiak Sciences' Retinal Pipeline Progress and Hold Rating
Kodiak Sciences Analyst Ratings
HC Wainwright & Co. Reiterates Neutral on Kodiak Sciences, Maintains $3 Price Target
Barclays Maintains Kodiak Sciences(KOD.US) With Sell Rating, Raises Target Price to $4
Barclays Remains a Sell on Kodiak Sciences (KOD)
Evercore Initiates Kodiak Sciences(KOD.US) With Buy Rating
Barclays Releases a Sell Rating on Kodiak Sciences (KOD)
Goldman Sachs Maintains Kodiak Sciences(KOD.US) With Sell Rating, Maintains Target Price $2
H.C. Wainwright Maintains Kodiak Sciences(KOD.US) With Hold Rating, Maintains Target Price $3
Kodiak Sciences Price Target Announced at $3.00/Share by HC Wainwright & Co.
Kodiak Sciences Analyst Ratings
H.C. Wainwright Initiates Kodiak Sciences(KOD.US) With Hold Rating, Announces Target Price $3
Evaluating Kodiak Sciences: A Hold Rating Amidst Clinical Setbacks and Competitive Pressures
Analysts Offer Insights on Healthcare Companies: Kodiak Sciences (KOD) and Pro Medicus Limited (OtherPMCUF)
Kodiak Sciences (KOD) Receives a Sell From Barclays
Kodiak Sciences Analyst Ratings
Kodiak Sciences Analyst Ratings
Barclays Maintains Underweight on Kodiak Sciences, Raises Price Target to $3
Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Walgreens Boots Alliance (WBA) and Kodiak Sciences (KOD)